Liver X Receptor Agonist Alleviated High Glucose-Induced Endothelial Progenitor Cell Dysfunction via Inhibition of Reactive Oxygen Species and Activation of AMP-Activated Protein Kinase

Microcirculation

Volumn 19, Issue 6, 2012, Pages 547-553

  Li, Xiaoxia ^a   Song, Yimeng ^a   Han, Yingying ^a   Wang, Dawei ^a   Zhu, Yi ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Adenosine monophosphate activated protein kinase; Endothelial progenitor cell; Liver X receptor agonist TO901317; Reactive oxygen species

Indexed keywords

ADENYLATE KINASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; LIVER X RECEPTOR AGONIST; N (2,2,2 TRIFLUOROETHYL) N [4 (2,2,2 TRIFLUORO 1 HYDROXY 1 TRIFLUOROMETHYLETHYL)PHENYL]BENZENESULFONAMIDE; REACTIVE OXYGEN METABOLITE;

ANGIOGENESIS; ANTIOXIDANT ACTIVITY; ARTICLE; CELL ADHESION; CELL MIGRATION; CONTROLLED STUDY; CYTOLOGY; DOWN REGULATION; DRUG MECHANISM; ENDOTHELIAL PROGENITOR CELL; ENZYME ACTIVATION; HUMAN; HUMAN CELL; NEWBORN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING;

AMP-ACTIVATED PROTEIN KINASES; CELL ADHESION; CELL MOVEMENT; CELLS, CULTURED; ENDOTHELIAL CELLS; ENZYME ACTIVATION; FEMALE; GLUCOSE; HUMANS; HYDROCARBONS, FLUORINATED; MALE; NEOVASCULARIZATION, PHYSIOLOGIC; ORPHAN NUCLEAR RECEPTORS; REACTIVE OXYGEN SPECIES; STEM CELLS; SULFONAMIDES; SWEETENING AGENTS; TIME FACTORS;

EID: 84864775953     PISSN: 10739688     EISSN: 15498719     Source Type: Journal    
DOI: 10.1111/j.1549-8719.2012.00186.x     Document Type: Article

References (29)

1. Chen Q, Dong L, Wang L, Kang L, Xu B. Advanced glycation end products impair function of late endothelial progenitor cells through effects on protein kinase Akt and cyclooxygenase-2. Biochem Biophys Res Commun 381: 192-197, 2009.
2. Chen Z, Peng IC, Sun W, Su MI, Hsu PH, Fu Y, Zhu Y, DeFea K, Pan S, Tsai MD, Shyy JY. AMP-activated protein kinase functionally phosphorylates endothelial nitric oxide synthase Ser633. Circ Res 104: 496-505, 2009.
3. Fadini GP, Sartore S, Agostini C, Avogaro A. Significance of endothelial progenitor cells in subjects with diabetes. Diabetes Care 30: 1305-1313, 2007.
4. Fadini GP, Sartore S, Albiero M, Baesso I, Murphy E, Menegolo M, Grego F, Vigili de Kreutzenberg S, Tiengo A, Agostini C, Avogaro A. Number and function of endothelial progenitor cells as a marker of severity for diabetic vasculopathy. Arterioscler Thromb Vasc Biol 26: 2140-2146, 2006.
5. Gomez-Cerezo JF, Pagan-Munoz B, Lopez-Rodriguez M, Estebanez-Munoz M, Barbado-Hernandez FJ. The role of endothelial progenitor cells and statins in endothelial function: a review. Cardiovasc Hematol Agents Med Chem 5: 265-272, 2007.
6. Li X, Han Y, Pang W, Li C, Xie X, Shyy JY, Zhu Y. AMP-activated protein kinase promotes the differentiation of endothelial progenitor cells. Arterioscler Thromb Vasc Biol 28: 1789-1795, 2008.
7. Loomans CJ, de Koning EJ, Staal FJ, Rookmaaker MB, Verseyden C, de Boer HC, Verhaar MC, Braam B, Rabelink TJ, van Zonneveld AJ Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes. Diabetes 53: 195-199, 2004.
8. Mohler ER 3rd, Shi Y, Moore J, Bantly A, Hamamdzic D, Yoder M, Rader DJ, Putt M, Zhang L, Parmacek M, Wilensky RL. Diabetes reduces bone marrow and circulating porcine endothelial progenitor cells, an effect ameliorated by atorvastatin and independent of cholesterol. Cytometry 75: 75-82, 2009.
9. Morello F, Saglio E, Noghero A, Schiavone D, Williams TA, Verhovez A, Bussolino F, Veglio F, Mulatero P. LXR-activating oxysterols induce the expression of inflammatory markers in endothelial cells through LXR-independent mechanisms. Atherosclerosis 207: 38-44, 2009.
10. Ohashi K, Ouchi N, Higuchi A, Shaw RJ, Walsh K. LKB1 deficiency in Tie2-Cre-expressing cells impairs ischemia-induced angiogenesis. J Biol Chem 285: 22291-22298, 2010.
11. Panzenboeck U, Kratzer I, Sovic A, Wintersperger A, Bernhart E, Hammer A, Malle E, Sattler W. Regulatory effects of synthetic liver X receptor- and peroxisome-proliferator activated receptor agonists on sterol transport pathways in polarized cerebrovascular endothelial cells. Int J Biochem Cell Biol 38: 1314-1329, 2006.
12. Richardson MR, Yoder MC. Endothelial progenitor cells: quo vadis? J Mol Cell Cardiol 50: 266-272, 2011.
13. Roberts N, Xiao Q, Weir G, Xu Q, Jahangiri M. Endothelial progenitor cells are mobilized after cardiac surgery. Ann Thorac Surg 83: 598-605, 2007.
14. Shimbo D, Muntner P, Mann D, Viera AJ, Homma S, Polak JF, Barr RG, Herrington D, Shea S. Endothelial dysfunction and the risk of hypertension: the multi-ethnic study of atherosclerosis. Hypertension 55: 1210-1216, 2010.
15. Silvestre JS. Vascular progenitor cells and diabetes: role in postischemic neovascularisation. Diabetes Metab 34(Suppl. 1): S33-S36, 2008.
16. Song L, Yang YJ, Dong QT, Qian HY, Xu H, Meng XM, Tang Y. [Atorvastatin protects swine bone marrow mesenchymal stem cells from apoptosis through AMPK but not PI3K/Akt pathway]. Zhonghua xin xue guan bing za zhi 39: 1033-1038, 2011.
17. Verschuren L, de Vries-van der Weij J, Zadelaar S, Kleemann R, Kooistra T. LXR agonist suppresses atherosclerotic lesion growth and promotes lesion regression in apoE*3Leiden mice: time course and mechanisms. J Lipid Res 50: 301-311, 2009.
18. Wang CH, Ting MK, Verma S, Kuo LT, Yang NI, Hsieh IC, Wang SY, Hung A, Cherng WJ. Pioglitazone increases the numbers and improves the functional capacity of endothelial progenitor cells in patients with diabetes mellitus. Am Heart J 152: e1051-1508, 2006.
19. Wang L, Zheng J, Bai X, Liu B, Liu CJ, Xu Q, Zhu Y, Wang N, Kong W, Wang X. ADAMTS-7 mediates vascular smooth muscle cell migration and neointima formation in balloon-injured rat arteries. Circ Res 104: 688-698, 2009.
20. Xiao Q, Kiechl S, Patel S, Oberhollenzer F, Weger S, Mayr A, Metzler B, Reindl M, Hu Y, Willeit J, Xu Q. Endothelial progenitor cells, cardiovascular risk factors, cytokine levels and atherosclerosis-results from a large population-based study. PLoS ONE 2: e975, 2007.
21. Xu QB Endothelial progenitor cells in angiogenesis. Sheng li xue bao: [Acta physiologica Sinica] 57: 1-6, 2005.
22. Xu MG, Men LN, Zhao CY, Zhao X, Wang YX, Meng XC, Shen DR, Meng BY, Zhang Q, Wang T. The number and function of circulating endothelial progenitor cells in patients with Kawasaki disease. Eur J Pediatr 169: 289-296, 2010.
23. Yang J, Craddock L, Hong S, Liu ZM. AMP-activated protein kinase suppresses LXR-dependent sterol regulatory element-binding protein-1c transcription in rat hepatoma McA-RH7777 cells. J Cell Biochem 106: 414-426, 2009.
24. Yap F, Craddock L, Yang J. Mechanism of AMPK suppression of LXR-dependent Srebp-1c transcription. Int J Biol Sci 7: 645-650, 2011.
25. Zampetaki A, Kirton JP, Xu Q. Vascular repair by endothelial progenitor cells. Cardiovasc Res 78: 413-421, 2008.
26. Zardi EM, Afeltra A. Endothelial dysfunction and vascular stiffness in systemic lupus erythematosus: are they early markers of subclinical atherosclerosis? Autoimmun Rev 9: 684-686, 2010.
27. Zhang Z, Ito WD, Hopfner U, Bohmert B, Kremer M, Reckhenrich AK, Harder Y, Lund N, Kruse C, Machens HG, Egana JT. The role of single cell derived vascular resident endothelial progenitor cells in the enhancement of vascularization in scaffold-based skin regeneration. Biomaterials 32: 4109-4117, 2011.
28. Zhong X, Xiu LL, Wei GH, Liu YY, Su L, Cao XP, Li YB, Xiao HP. Bezafibrate enhances proliferation and differentiation of osteoblastic MC3T3-E1 cells via AMPK and eNOS activation. Acta Pharmacol Sin 32: 591-600, 2011.
29. Zhu Y, Liao H, Xie X, Yuan Y, Lee TS, Wang N, Wang X, Shyy JY, Stemerman MB. Oxidized LDL downregulates ATP-binding cassette transporter-1 in human vascular endothelial cells via inhibiting liver X receptor (LXR). Cardiovasc Res 68: 425-432, 2005.